206 related articles for article (PubMed ID: 34215303)
1. SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer's disease.
Bichmann M; Prat Oriol N; Ercan-Herbst E; Schöndorf DC; Gomez Ramos B; Schwärzler V; Neu M; Schlüter A; Wang X; Jin L; Hu C; Tian Y; Ried JS; Haberkant P; Gasparini L; Ehrnhoefer DE
Mol Neurodegener; 2021 Jul; 16(1):46. PubMed ID: 34215303
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.
Huseby CJ; Hoffman CN; Cooper GL; Cocuron JC; Alonso AP; Thomas SN; Yang AJ; Kuret J
J Alzheimers Dis; 2019; 71(3):979-991. PubMed ID: 31450505
[TBL] [Abstract][Full Text] [Related]
3. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
[TBL] [Abstract][Full Text] [Related]
4. Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.
Kyalu Ngoie Zola N; Balty C; Pyr Dit Ruys S; Vanparys AAT; Huyghe NDG; Herinckx G; Johanns M; Boyer E; Kienlen-Campard P; Rider MH; Vertommen D; Hanseeuw BJ
Nat Commun; 2023 Jun; 14(1):3706. PubMed ID: 37349319
[TBL] [Abstract][Full Text] [Related]
5. Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach.
Thomas SN; Funk KE; Wan Y; Liao Z; Davies P; Kuret J; Yang AJ
Acta Neuropathol; 2012 Jan; 123(1):105-17. PubMed ID: 22033876
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
[TBL] [Abstract][Full Text] [Related]
7. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
Dave N; Vural AS; Piras IS; Winslow W; Surendra L; Winstone JK; Beach TG; Huentelman MJ; Velazquez R
Acta Neuropathol; 2021 Aug; 142(2):279-294. PubMed ID: 33978814
[TBL] [Abstract][Full Text] [Related]
8. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.
Thomas SN; Yang AJ
Methods Mol Biol; 2017; 1523():161-177. PubMed ID: 27975250
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Methylation and Phosphorylation Stoichiometry.
Ayoub CA; Moore KI; Kuret J
Methods Mol Biol; 2024; 2754():221-235. PubMed ID: 38512670
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice.
Hastings NB; Wang X; Song L; Butts BD; Grotz D; Hargreaves R; Fred Hess J; Hong KK; Huang CR; Hyde L; Laverty M; Lee J; Levitan D; Lu SX; Maguire M; Mahadomrongkul V; McEachern EJ; Ouyang X; Rosahl TW; Selnick H; Stanton M; Terracina G; Vocadlo DJ; Wang G; Duffy JL; Parker EM; Zhang L
Mol Neurodegener; 2017 May; 12(1):39. PubMed ID: 28521765
[TBL] [Abstract][Full Text] [Related]
12. Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation.
Xia Y; Bell BM; Giasson BI
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175990
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
[TBL] [Abstract][Full Text] [Related]
14. A validated antibody panel for the characterization of tau post-translational modifications.
Ercan E; Eid S; Weber C; Kowalski A; Bichmann M; Behrendt A; Matthes F; Krauss S; Reinhardt P; Fulle S; Ehrnhoefer DE
Mol Neurodegener; 2017 Nov; 12(1):87. PubMed ID: 29157277
[TBL] [Abstract][Full Text] [Related]
15. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.
Ando K; Dourlen P; Sambo AV; Bretteville A; Bélarbi K; Vingtdeux V; Eddarkaoui S; Drobecq H; Ghestem A; Bégard S; Demey-Thomas E; Melnyk P; Smet C; Lippens G; Maurage CA; Caillet-Boudin ML; Verdier Y; Vinh J; Landrieu I; Galas MC; Blum D; Hamdane M; Sergeant N; Buée L
Neurobiol Aging; 2013 Mar; 34(3):757-69. PubMed ID: 22926167
[TBL] [Abstract][Full Text] [Related]
16. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.
Kopeikina KJ; Carlson GA; Pitstick R; Ludvigson AE; Peters A; Luebke JI; Koffie RM; Frosch MP; Hyman BT; Spires-Jones TL
Am J Pathol; 2011 Oct; 179(4):2071-82. PubMed ID: 21854751
[TBL] [Abstract][Full Text] [Related]
17. Methylation at a conserved lysine residue modulates tau assembly and cellular functions.
Shams H; Matsunaga A; Ma Q; Mofrad MRK; Didonna A
Mol Cell Neurosci; 2022 May; 120():103707. PubMed ID: 35231567
[TBL] [Abstract][Full Text] [Related]
18. The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.
Guha S; Johnson GVW; Nehrke K
Mol Neurobiol; 2020 Dec; 57(12):5103-5120. PubMed ID: 32851560
[TBL] [Abstract][Full Text] [Related]
19. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
20. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]